stock
Crescent Biopharma, Inc.
NASDAQ | CBIO
15.89
USD
+0.00
(+0.00%
)AT CLOSE (AS OF Jul 3, 2025)
$293M
MARKET CAP
-
P/E Ratio
-
EPS
$63
52 Week High
$11
52 Week Low
LIFE SCIENCES
Sector
CBIO Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
CBIO Technicals
CBIO Earnings
Earnings Performance
CBIO Profile
Crescent Biopharma, Inc. Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on developing candidates for protease products in the fields of hemostasis and complement regulation. The company is headquartered in South San Francisco, California.
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.